Navigation Links
Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma
Date:9/30/2013

sks, uncertainties and assumptions that could cause actual results to differ materially from those described.  All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and Form 8-K.  Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of Sept. 30, 2013, and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans.  The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. T
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Amgen And ShanghaiTech University Announce Plans For Amgen China R&D Center To Open On ShanghaiTech Campus
2. Amgen And Servier Complete Product Collaboration Transaction
3. Amgen Announces 2013 Third Quarter Dividend
4. Technical Briefing: Amgen, PDL BioPharma, Questcor Pharma, and BioCryst Pharma
5. Amgen And Servier Announce Product Collaboration
6. Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations
7. Amgen And AstraZeneca Highlight Data To Be Presented At European League Against Rheumatism Annual Meeting
8. Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma
9. Amgen Announces 2013 Second Quarter Dividend
10. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
11. Amgen Announces Webcast of 2012 Fourth Quarter and Full Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 ... of the biomaterial family and are increasingly becoming ... body fluids and tissues without having a negative ... used as tissue replacement and tissue repair materials ... materials such as ceramics, glass, glass-ceramics, and composites. ...
(Date:9/23/2014)... Kamal Rashid , PhD, director of ... Center (BETC) and research professor of biology and biotechnology ... an international two-day event focused on biomanufacturing set for ... the event will bring together leaders of companies from ... and produce human therapeutics. “The growth curve for biomanufacturing ...
(Date:9/23/2014)... 2014 This is a professional ... the Phenolic Resin industry in Global and China.The ... including definitions, applications and industry chain structure. Global ... provided with a focus on history, developments, trends ... between the international and Chinese situation is also ...
(Date:9/23/2014)... de Reuil, France (PRWEB) September 23, 2014 ... to protection of laboratory personnel since 1968 and Burdinola, ... the development of a new filtered fume hood. ... above their laboratory fume hood, Burdinola will now offer ... for filtering a wide range of chemicals, best-in-class detection ...
Breaking Biology Technology:Global Bioactive Material Market 2014-2018 2Worcester Polytechnic Institute's Biomanufacturing Expertise to be Featured in Berlin 2Worcester Polytechnic Institute's Biomanufacturing Expertise to be Featured in Berlin 3Phenolic Resin Industry (International, China) Development Policy and Plan Now Available at ReportsnReports.com 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2
... , RESTON, Va., July 9 Mirixa Corporation, the ... the hiring of three new members to its growing ... FASCP, Kim Swiger, RPh, and Paul Miller, MS, RPh. ... closely with Mirixa,s pharmacy partners, state and national pharmacy ...
... FRANCISCO, Calif., July 9 Poniard Pharmaceuticals, Inc. (Nasdaq: ... therapies, today announced the appointment of Gary A. Lyons, to ... number of directors on the Poniard board to ten. , ... to help guide us as we move toward our goal ...
... , SUNNYVALE, Calif., July 9 Cepheid (Nasdaq: CPHD ... second quarter ended June 30, 2009, on Thursday, July 30, 2009, ... will host a management presentation at 2 p.m. Pacific Time on ... the live webcast, please visit Cepheid,s website at www.cepheid.com/investors ...
Cached Biology Technology:Mirixa Corporation Announces Key New Hires 2Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors 2Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors 3Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast 2
(Date:9/23/2014)... Scientists have scoured cow rumens and termite guts for ... for the production of next-generation biofuels, but some of ... human lower intestine, researchers report. , Their study ... Academy of Sciences , is the first to use ... the human gut can digest fiber, breaking it down ...
(Date:9/23/2014)... could be as good for your mental as your ... by the University of Warwick,s Medical School using data ... BMJ Open focused on mental wellbeing and ... associated with an individual,s fruit and vegetable consumption. , ... or more portions of fruit and vegetables a day, ...
(Date:9/23/2014)... organisms, including humans, have parasitic DNA fragments called "jumping ... instructions in the process. And that phenomenon can result ... the University of Rochester now report that the "jumping ... when a multi-function protein stops keeping them in check ... In a study published today in Nature Communications ...
Breaking Biology News(10 mins):Search for better biofuels microbes leads to the human gut 2Search for better biofuels microbes leads to the human gut 3Eating five a day may keep the blues away 2A multi-function protein is key to stopping genomic parasites from 'jumping' 2
... replacement surgeries can help relieve joint pain common ... the debris from prosthetic joints leads to aseptic ... a Wayne State University researcher determined that the ... disintegration. There was one caveat, however: there are ...
... female mosquito cannot tell if the male that she has ... her eggs, according to a new study from scientists at ... journal Proceedings of the National Academy of Sciences , ... of malaria by interfering with the mosquitoes, ability to reproduce. ...
... ALAMOS, New Mexico, August 8, 2011A Los Alamos National ... the first time the critical role that an elusive ... aid in treatment of peptic ulcers or acid reflux ... waste into transportation fuels. In a paper appearing ...
Cached Biology News:Wayne State researcher discovers antibiotic useful for localized treatment of bone wear 2Mosquitoes can't spot a spermless mate 2Mosquitoes can't spot a spermless mate 3Researchers use neutrons to spy on the elusive hydronium ion 2
HAMP Immunogen: HAMP (AAH20612, 25 a.a. ~ 85 a.a) full length recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... peptide transporter 2 (APT2) ... transporter PSF2) (Peptide supply ... transporter involved in antigen ... Antigen: ...
Raised to arginine vasopressin coupled to bovine thyroglobulin with carbodiimide ....
Chicken polyclonal to HAGH ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to N terminal amino acids 110-260 of Human HAGH. Entrez GeneID: 3029 Swiss ...
Biology Products: